Vaxart, Inc.
Overview
Vaxart, Inc. is a clinical-stage biotechnology company focused on developing oral recombinant vaccines administered by tablet rather than by injection. The company aims to transform vaccine delivery with its proprietary oral vaccine platform and is actively working on vaccines for various infectious diseases.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Vaxart, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Related companies
Altimmune, Inc.
United States
American Cyanamid Company (as Wyeth-Ayerst Laboratories)
United States
Dynavax Technologies Corporation
United States
Emergent BioSolutions Inc.
United States
FHI Clinical, Inc.
United States
Iliad Biotechnologies, LLC
United States
Merck & Co., Inc.
United States
Merck Sharp & Dohme LLC
United States
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.